thumbnail image
  • Home
  • About us
    • Company
    • CORE TEAM
    • QUALITY UNIT
    • BUSINESS
  • Services
    • GENERAL TOXICOLOGY
    • DART
    • GENETIC TOXICOLOGY
    • SAFETY PHARMACOLOGY
    • PK/TK
    • EFFICACY STUDY
    • OPHTHALMIC LAB
    • CARCINOGENES
    • Project Management System for Client
  • Laboratories
    • PATHOLOGY LAB
    • CLINICAL LAB
    • BIO-ANALYSIS
    • TEST ARTICLE LAB
  • Animal Welfare
    • Animal welfare
  • News&Events
  • Home
  • About us
    • Company
    • CORE TEAM
    • QUALITY UNIT
    • BUSINESS
  • Services
    • GENERAL TOXICOLOGY
    • DART
    • GENETIC TOXICOLOGY
    • SAFETY PHARMACOLOGY
    • PK/TK
    • EFFICACY STUDY
    • OPHTHALMIC LAB
    • CARCINOGENES
    • Project Management System for Client
  • Laboratories
    • PATHOLOGY LAB
    • CLINICAL LAB
    • BIO-ANALYSIS
    • TEST ARTICLE LAB
  • Animal Welfare
    • Animal welfare
  • News&Events
    • GENERAL TOXICOLOGY

      Our GLP general toxicology team conducts GLP general toxicology studies in full compliance with CFDA, FDA, OECD or ICH regulations. The team has 15 study directors, of which 7 have over 13 years' of experience in pre-clinic drug development.The team is good at finding, analyzing and solving drug development problems innovatively. The team offer valuable expertise in standard or customized study protocol design to our clients based on nature of the substances and specific regulatory needs of clients.

       

      Since 2002, our general toxicology team has accomplished over thousand of studies for over 300 new drugs. They are well experienced in a wide range of administration routes, including nasal feeding, nasal cavity, rectum, urethra, vagina,implant and micro-pump continuous infusion at constant speed, in rodent and non-rodent species.

      SERVICES

      • Dose Finding Studies (Rodent and Non-rodent)
      •  Single Dose / Acute Toxicity (Rodent and Non-rodent)
      • Repeat Dose / Sub-chronic and Chronic (Rodent and Non-rodent)
      • Formulation Safety Studies (Irritation, Sensitization and Hemolysis)

         

       

       

      所有文章
      ×
      成都华西海圻医药科技有限公司(English)
      成都华西海圻医药科技有限公司,国家成都新药安全性评价中心
      https://user-assets.sxlcdn.com/images/397921/Fuuup8iHbnSRXKbrJb7f8RgJ3o2r.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png
      Cookie的使用
      我们使用cookies来确保流畅的浏览体验。若继续,我们认为你接受使用cookies。
      了解更多